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Recent genome-scale analyses of genetic interactions in model microbes have revealed the inherent func-
tional organization of the cell as a dense network of highly interconnected pathways. While classical one
gene at a time paradigms offer limited insight into cellular systems, genome-scale approaches are making
considerable headway. Indeed, where small organic compounds are ideal probes of biological complexity,
systematic chemical genomic methods are emerging as requisite and powerful approaches to describing
both the small molecule probe and network with which it interacts. Here, we highlight various chemical
genomic approaches that are being pioneered in model microbes.Introduction
In light of the explosion in sequencing efforts and the expansion in
genome-scale approaches to chart genetic interactions, our view
of the cell is changing. With this newwealth of information comes
a new appreciation and understanding of complex biological
systems.Whileclassicalgeneticshasplayedapivotal role ineluci-
dating biology by investigating relationships between genes and
phenotypes, we are now increasingly turning to small molecules
asmodulators. The thesis is that smallmolecules are ideal probes
of biological systems with advantages over genetic manipulation.
It has been pointed out that genetic inactivation is effectively
permanent and technically tedious, even in the most tractable
systems, and that these limitations can be circumvented through
the use of small molecules (Specht and Shokat, 2002).
Probing biological functions with small molecules has helped
elucidate functional roles for enigmatic areas of biology in which
conventional genetic and biochemical approaches have pro-
vided limited understanding. Insights gained over the last
80 years into microbial physiology have frequently come from
efforts to understand the mechanisms of action of antibiotics
discovered during this same period. Indeed, our understanding
of basic processes of nucleic acid, protein, and cell wall
synthesis has often been due to remarkable discoveries inmodel
microbes, enabled by antibiotic compounds. Despite the advan-
tages of small molecules as probes, efforts to discover and char-
acterize their interactions within biological systems have been
narrowly focused and limited for the most part to traditional
nongenomic approaches. The new understanding of cellular
complexity that has come from large-scale studies of protein
and genetic interactions (Butland et al., 2005; Costanzo et al.,
2010; Faith et al., 2007; Jeong et al., 2001), has sparked
a demand for genome-scale techniques to characterize both
new and old chemical probes. Such chemical genomic method-
ologies, it is reasoned, more fittingly describe complex biology
by informing on how network components interact to produce
physiological responses or maintain phenotypic stability under
states of stress.624 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rigAlong with providing a global view of the biological system
under study, chemical genomics also provides remarkable new
tools to understand the mechanism of action of small molecules
of unknown function. This is a daunting hurdle in both new probe
development and in drug discovery (Burdine and Kodadek,
2004). Classically, protein targets have been identified through
biochemical screens using labeled or immobilized molecules.
A growing repertoire of new approaches to study the mode of
action of small molecules now includes transcriptional profiling
(Shaw and Morrow, 2003), network inference models (Gardner
et al., 2003), small-molecule (Bradner et al., 2006; Duffner
et al., 2007), as well as protein microarrays (MacBeath and
Schreiber, 2000). Further, breakthrough genome-scale ap-
proaches in Saccaromyces cerevisiae, which take advantage
of its diploid nature, have emerged and been successful in iden-
tifying cellular targets of small molecules (Baetz et al., 2004; Gia-
ever et al., 1999; Lum et al., 2004; Parsons et al., 2004). Chemical
genomic strategies have also advanced the field of natural
product research by facilitating the characterization of the
ever-increasing repertoire of novel natural products (Jiang
et al., 2008; Parsons et al., 2006). These studies in yeast were
among the first to yield biological insights in response to chem-
ical perturbants on a network level and have inspired the estab-
lishment of postgenomic tools in a variety of bacterial organisms.
The present review emphasizes the successful use of these
approaches in model microbes, principally bacteria and yeast.
Chemical genomics in S. cerevisiae has been recently reviewed
(Hoon et al., 2008b) and accordingly, we have emphasized prin-
ciples and included work in bacterial systems here. The value of
genome-wide approaches in tackling cellular complexity and
exploiting the activity of small molecules is enabling biological
investigations previously not deemed possible. Herein, we
describe the emerging tools for chemical genomic studies
(Figure 1), including genome-scale clone sets, microarray-based
transcriptional profiling, chemical proteomics, and computa-
tional methodologies, highlighting success stories of intriguing
biological and mechanistic findings.hts reserved
Figure 1. Experimental Approaches for the
Global Investigation of Protein Function and
Identification of Biological Probes
Schematically shown are various genomic meth-
odologies, which when used in parallel with small
molecules, aid in understanding the complex
cellular network (middle). Depicted are small mole-
cules that have been identified using the respec-
tive methods (1, 3, 7) or used to perturb the cellular
system (2, 4, 5, 6). (1) MAC-13243 (Pathania et al.,
2009), (2) tetracycline (Bollenbach et al., 2009), (3)
ECi8 (Shen et al., 2010), (4) gentamicin (Kohanski
et al., 2008), (5) b-lactam probe (Staub and Sieber,
2009), (6) moiramide B (Hughes et al., 2000), (7)
DMPI (Donald et al., 2009).
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to Infer Function
With the availability of comprehensive genome sequence infor-
mation, it was inevitable that efforts would follow to construct
elaborate genome-scale clone sets (Table 1) well suited to
studying genetic and chemical-genetic interactions. Chemical
genomics has been best established with extraordinary genomic
tools available for the baker’s yeast Saccharomyces cerevisiae
(Hoon et al., 2008b). Among the most exciting developments in
genome-wide approaches has been the creation of barcoded
homozygous and heterozygous deletion clone sets (Giaever
et al., 2002), where high-throughput competitive growth assays
have allowed the parallel study of multiple S. cerevisiae strains
(Giaever et al., 2002; Shoemaker et al., 1996; Winzeler et al.,
1999). Thus, by exploiting the diploid nature of S. cerevisiae,
the effect a small molecule has on the fitness of a particular strain
can be examined when gene dosage is tuned from 0% (homozy-
gous deletions) (Lee et al., 2005; Parsons et al., 2006) to 50%
(heterozygous deletions) (Giaever et al., 2004; Parsons et al.,
2006) to >100% (overexpressors) (Butcher et al., 2006; Gelperin
et al., 2005; Luesch et al., 2005).
Using both the heterozygous and homozygous deletion
collections, Hillenmeyer et al. looked to uncover a phenotype
for all genes in S. cerevisiae (Hillenmeyer et al., 2008). In the
presence of over 400 small molecules and diverse environ-
mental stresses, the study revealed that 97% of the gene dele-
tions exhibited a measurable growth defect, suggesting that
nearly all genes are essential under at least one condition.
The fact that only 20% of the S. cerevisiae genome was
thought to be essential under rich media conditions highlights
the power of this chemical genomic approach to uncover
a phenotype for virtually all of the remaining genes, and
provides additional insight into the role of so-called nonessen-
tial genes. Although these techniques are not completely trans-
ferrable to monoploid organisms, the work performed inChemistry & Biology 17, June 25, 2010S. cerevisiae nicely exemplifies the utility
of altering gene dosage to identify
chemical-genetic interactions and pro-
vided the groundwork to extend chemi-
cal genomics to bacteria.
Reducing Gene Dosage
Mutagenesis experiments have had
a long-standing role in determining genedispensability and investigating genetic interactions. Most
recently, systematic gene knockout libraries of all possible dele-
tion mutants have recently been completed in a variety of bacte-
rial species (Table 1). These have particular utility in chemical
genomics (Figure 2A). Decreasing the dosage of a given gene
can lead to any of three possible outcomes with respect to the
biological activity of a compound: no effect, enhancement, or
suppression of phenotype. Systematic enhancement screens
using the E. coli deletion collection have focused on known anti-
biotics to date and revealed signature chemical-genetic interac-
tions that enhance the growth inhibition exerted by antibiotics
(Tamae et al., 2008). These studies have huge potential in facili-
tating mechanism of action studies. Indeed, genetic enhancers
of the action of gentamicin provided key insights that ultimately
led to the understanding that aminoglycosides mediate cell
death through the production of toxic hydroxyl radicals (Kohan-
ski et al., 2007, 2008).
Other genome-scale chemical-genetic enhancement screens
have proven useful in identifying genes implicated in intrinsic
multidrug resistance (Breidenstein et al., 2008; Duo et al.,
2008), as well as those responsible for maintaining a population
of persister cells (Hansen et al., 2008). However, unlike deletion
libraries in yeast, the bacterial counterparts do not contain
molecular barcodes, limiting their ability to be used in pooled
competitive assays. To this end, a set of barcoded deletions in
E. coli is currently being generated, allowing for future parallel
analysis of competitive growth assays similar to those in yeast
(Mori et al., 2009). Moreover, two groups have recently reported
methods for the high-throughput generation of double deletions
in E. coli (Butland et al., 2008; Typas et al., 2008), further expand-
ing the current tool set for microbial chemical genomics. Indeed,
systematic studies of the interactions of double deletions with,
e.g., growth inhibitory small molecules, would allow for higher-
order studies of the cellular network and its capacity to buffer
the effects of multiple perturbations.ª2010 Elsevier Ltd All rights reserved 625
Table 1. Genome-Scale Clone Sets in Model Microbes
Organism Reference Note
Gene knockdown
Bacillus subtilis Kobayashi et al.
(2003)
Candida albicans Xu et al. (2007) Heterozygous
barcoded
Escherichia coli Baba et al. (2006)
Helicobacter pylori Salama et al. (2004)
Pseudomonas
aeruginosa PA01
Jacobs et al. (2003)
Pseudomonas
aeruginosa PA14
Liberati et al. (2006)
Saccharomyces
cerevisiae
Giaever et al. (2002);
Winzeler et al. (1999)
Homo/heterozygous
barcoded
Staphylococcus
aureus
Donald et al. (2009) Antisense
knockdown
Overexpression
Escherichia coli Kitagawa et al. (2005)
Neisseria
gonorrhoeae
Brettin et al. (2005)
Pseudomonas
aeruginosa
Labaer et al. (2004)
Saccharomyces
cerevisiae
Gelperin et al. (2005)
Staphylococcus
aureus
Brandner et al. (2008)
Promoter-reporter
Escherichia coli Zaslaver et al. (2006) gfp-promoter fusions
Salmonella
typhimurium
Goh et al. (2002) Promoter-lux
reporter fusions
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provided an additional means to explore small molecule effects
by controlled reduction of gene expression (Figure 2B). Recently,
Donald et al. arrayed xylose-inducible antisense RNA strains
corresponding to 245 essential genes in Staphylococcus aureus
(Donald et al., 2009). This antisense RNA system led to the
discovery of new cell wall inhibitors, suggested to inhibit
SAV1754, a previously uncharacterized cell surface transmem-
brane protein involved in cell wall assembly (Huber et al.,
2009). SAV1754, structurally related to the E. coli peptidoglycan
flippase, MurJ (Ruiz, 2008), is thus speculated to perform an
analogous function in Gram positive bacteria. Profiles generated
using antisense knockdown not only capture direct targets, but
also pathway-related genes by exploring various strain sensitiv-
ities in the presence of the small molecule. A significant limitation
of this array is the lack of genome coverage; it is limited to those
genes essential for growth, excluding the possibility of charting
chemical-genetic interactions with the dispensable gene set.
A counter point to this concern argues that the targets of inhibi-
tory small molecules should be essential for cell viability (Chalker
and Lunsford, 2002). Thus, mechanism of action studies needn’t
explore chemical-genetic interactions with the dispensable frac-
tion of the genome. Nevertheless, suppression and enhance-
ment phenotypes can reveal interactions that reflect the under-626 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All riglying cellular network with which small molecules are
interacting (Prelich, 1999), highlighting the important role of dele-
tion clone sets in understanding mechanism of action.
Increasing Gene Dosage
Libraries designed for high expression of each gene through an
inducible promoter have been increasingly exploited for small
molecule target identification (Butcher et al., 2006; Li et al.,
2004; Luesch et al., 2005; Pathania et al., 2009), where the pres-
ence of the target gene inmultiple copies leads to suppression of
growth inhibition by a particular small molecule (Figure 2C). Our
group recently reported on the first systematic use of this meth-
odology using the E. coli overexpression clone set (A Complete
Set of E. coli K-12 ORF Archive [ASKA]) (Pathania et al., 2009).
Proof of principle experiments employed a panel of antibiotics
and revealed a unique set of chemical-genetic interactions for
each compound. A stringency analysis of the concentration
dependence of suppression revealed that known cellular targets
were typically encoded by those genes that suppressed the
highest doses of antibiotic. Of interest, the inhibitory action of
a novel molecule, MAC13243, was suppressed at high strin-
gency when the lipoprotein chaperone, LolA, was expressed at
high copy. Further physiological and biochemical experiments
suggested that MAC13243 is a new probe of lipoprotein traf-
ficking in bacteria (Pathania et al., 2009). Nevertheless, target
identification through suppression of growth inhibition is not
always straightforward; the inherent complexity of the cellular
network often leads to a variety of puzzling chemical-genetic
interactions.
A particularly innovative use of high-copy suppression was
that of Arnoldo and coworkers who used the methodology to
identify P. aeruginosa virulence factors (Arnoldo et al., 2008).
A yeast-basedmethodwas developed to screen forP. aeruginosa
genes, which when overexpressed, were growth inhibitory to
S. cerevisiae. Such genes were subsequently counter screened
against a library of small molecules to uncover compounds
which restored the growth of S. cerevisiae. An inhibitor of Exoen-
zyme S, a toxin of the P. aeruginosa type III secretion system,
was identified and subsequently shown to prevent P. aeruginosa
infection in mammalian cells. Integration of bacterial expression
systems into S. cerevisiae provides a unique platform for the
identification of novel virulence factors that can serve as poten-
tial antibacterial targets.
Like most techniques, diverse genome-scale chemical
genomic approaches appear to benefit from integration. Of
interest, several recent studies in yeast have combined efforts
that involve multiple genome-scale clone sets to provide
a more comprehensive and sensitive inference on small mole-
cule action (Hoon et al., 2008a; Kemmer et al., 2009; Yan et al.,
2009).
Microarray-Based Gene Expression Profiling
Chemical compounds lend themselves particularly well for gene-
expression profiling studies, whereby transcriptional effects of
small molecules can be documented using DNA microarrays.
In fact, studying the effect of a small molecule on the regulation
of gene expression has been at the forefront of recent chemical
genomic studies. These approaches have proven vital in the
global exploration of protein function, revealing novel insightshts reserved
Figure 2. Genome-Scale Clone Sets Aid in
Mode of Action (MOA) Determination and
Provide Insights on Biological Processes
(Biology) in Bacteria
Here, the red triangle represents the small mole-
cule and the pacman, a protein target of interest.
(A) Mutagenesis using deletion collections in the
presence of small molecules leads to death
when perturbing a redundant pathway.
(B) Reducing gene expression through antisense
RNA clone sets. (i) No antisense RNA expression
such that the protein target is available at wild-
type levels, requiring a certain amount of
compound for inhibition. (ii) AntisenseRNAexpres-
sion from an inducible plasmid knocks down the
amount of transcript, leading to reduced levels of
protein targets, thus requiring a lower concentra-
tion of compound for inhibition than in (i).
(C) Suppression using high-expression libraries,
whereby overexpression of a gene of interest in
the presence of a small molecule can restore life.
(D) Promoter-reporter construct libraries allow for
the detection of specific promoter activity (yellow
star) in the affected pathway perturbed by a small
molecule. For example, the small molecule
targets protein B, such that promoter activity
can be detected from both PA and PB, but not PZ.
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uncharted small molecules.
Mode of action studies using microarrays have frequently
involved comparative analyses with transcriptional profiles of
known inhibitors or regulatory proteins (Freiberg et al., 2005;
Hughes et al., 2000; Kung et al., 2005; Marton et al., 1998).
Indeed, with gene-expression profile databases rapidly expand-
ing, comparisons to available profiles can be readily made to
identify relevant cellular pathways of unknown small molecules.
Accordingly, the work by Kung et al. (2005) identified Cdk1 and
Pho85, two cyclin-dependent kinases, as the targets of the
novel inhibitor GW4000426 in S. cerevisiae through direct
comparison to microarray transcriptional signatures elicited by
specific pharmacological agents. Generation of drug reference
profiles presents the advantage of identifying all targets that
together lead to the cellular effects resulting from drug treat-
ment. GW4000426 was shown to simultaneously inhibit both
kinases, revealing the synthetic interaction of Cdk1 and
Pho85. In this case, the novel protein kinase inhibitor aided in
uncovering this unique cellular response through microarray-
based transcriptional profiling. Another interesting study by Frei-
berg et al. generated a collection of genome-wide expression
profiles of Bacillus subtilis in response to a panel of 14 diverse
antibiotics (Freiberg et al., 2005). In addition, the authors
extended their data sets with expression profiles from condi-
tional mutants of four distinct essential genes coding for
emerging antibacterial targets. As proof of principle, this refer-
ence compendium was used to pinpoint the molecular targets
of two novel antibiotics and also identified a novel mode of
action for moiramide B, based on inhibition of acetyl coenzyme
A carboxylase.Chemistry & BiIn addition to mechanistic studies, the development of micro-
array-based technology has provided the prospect to gain
a genome-wide understanding of changes within the organism’s
transcriptome in response to small molecules. In fact, chemical
genomic studies using transcriptional profiling have revealed
novel insights into a number of different cellular processes
following treatment with chemical compounds, such as anti-
cancer agents (Wu et al., 2004), metabolic analogs (Yu et al.,
2008), and DNA-damaging agents (Birrell et al., 2002; Lee
et al., 2005). An interesting study using the latter, aimed at further
expanding our knowledge of DNA damage, made use of the
collection of barcoded yeast deletion strains competitively
grown in the presence of various DNA-damaging agents (Lee
et al., 2005). This study shed light on the cell’s complex response
to DNA damage, uncovering 34 previously uncharacterized
genes involved in DNA repair, as well as novel epistatic interac-
tions between genes implicated in the defense mechanisms
against DNA-damaging agents. This global analysis further re-
vealed the genetic requirements important for resistance to the
various compounds, overall advancing our understanding of
the DNA-damage response. Indeed, powerful microarray-based
chemical-genomic technologies in S. cerevisiae are well estab-
lished, due to its robustness and ease of genetic modification,
allowing a thorough functional characterization of the genome
(Giaever et al., 1999; Hughes et al., 2000; Lum et al., 2004;
Parsons et al., 2004).
Similarly, microarray-based studies of gene expression
following treatment with small molecules have proven useful
strategies for mode of action predictions and biological studies
in prokaryotic organisms. A successful example was provided
by the recent work of Mendez-Ortiz et al. who were interestedology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 627
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molecule, 30,50-cyclic diguanylic acid (c-di-GMP), an important
second messenger that controls motility and adhesion in
bacteria (Mendez-Ortiz et al., 2006). Expression profiles of
E. coli in the presence of high levels of c-di-GMP, revealed its
effects on the transcriptional regulation of certain genes in the
cell, including several cell surface and membrane-bound
proteins. Expectedly, genes involved in motility and cell division
were altered, while elevated levels of c-di-GMP interestingly trig-
gered the transcription of 50 genes of unknown function, high-
lighting the complex regulatory mechanisms where c-di-GMP
takes part in bacterial metabolism.
Early genome-wide transcriptional profiling studies in Staphy-
lococcus aureus increased our understanding of cell wall active
antibiotics through the uncovering of a cell wall stress stimulon
(Utaida et al., 2003). Identification of genes in the presence of
oxacillin, D-cycloserine, or bacitracin, three antibiotics that
inhibit different steps in peptidoglycan synthesis, all lead to the
upregulation of a large number of common genes, including
ones that code for proteins involved in cell wall metabolism
and stress responses. This study provides insights into the
molecular events that take place following inhibition of peptido-
glycan synthesis in bacteria and deepens our understanding of
the inhibitory mode of action of some of the most common anti-
biotics. Such studies foreshadow the future evaluation and
comparison of the transcriptional responses to these antibiotics
in strains resistant to these compounds. Similarly, Kaldalu et al.
used transcriptional profiling in E. coli to show that, even with the
most mechanistically unrelated antibiotics, a subset of genes is
commonly affected in their transcriptional response, offering
fundamental insight into the basis of antibacterial activity of anti-
biotics and mechanisms of bacterial death (Kaldalu et al., 2004).
Promoter-Reporter Construct Libraries
Bacterial promoter-reporter construct libraries (Table 1) have
also found utility in chemical genomic studies in assessing tran-
scription patterns on a global level in response to small mole-
cules (Fischer et al., 2004; Goh et al., 2002; Yim et al., 2006)
(Figure 2D). In contrast to microarray technology, these libraries
provide high resolution, data-rich time courses of promoter
response to bioactive small molecules. These advantages facil-
itated the investigation of the action of antibiotics in Salmonella
typhimurium at subinhibitory concentrations (Davies et al.,
2006; Goh et al., 2002; Yim et al., 2006). Here, significant tran-
scriptional activation of various promoters revealed that antibi-
otics can have multiple effects on the cell by acting as chemical
signals to control bacterial metabolic processes, suggesting
a new role beyond therapeutic utility.
In 2006, Zaslaver et al. reported on the creation of a transcrip-
tional fusion promoter library in E. coli, where 2000 promoters
were fused to gfp (Zaslaver et al., 2006). Using this library, Bol-
lenbach et al. looked to shed light on the mechanism of suppres-
sive drug interactions between DNA and protein synthesis inhib-
itors, whereby the combination of the two allows the cells to
grow faster (Bollenbach et al., 2009). Examination of the expres-
sion profiles of 200 E. coli promoters in response to different
antibiotics revealed that ribosomal levels are not optimally regu-
lated under conditions of DNA stress, causing an imbalance
between DNA and protein levels. Reducing protein levels with628 Chemistry & Biology 17, June 25, 2010 ª2010 Elsevier Ltd All rigprotein synthesis inhibitors restores this imbalance allowing cells
to grow faster; this same trend is observedwhenmutations in the
ribosomal RNA operons impinge on ribosome synthesis (Bollen-
bach et al., 2009). Overall, promoter-reporter construct libraries
provide a unique look at expression dynamics in cells and can
reveal fascinating roles for even the most well-established
antibiotics.
Chemical Proteomics
Proteomic studies have long played an integral part in assessing
protein structure, function, and cellular interactions. Incorpo-
rating chemical strategies has provided efficient detection of
select classes of proteins, aswell as provided an effectivemeans
for subsequent isolation from the proteome. The realm of
increasingly diverse chemical moieties needed for chemical pro-
teomics has positioned synthetic chemistry as a crucial partner
for the success of this field. Overall, the study of chemical pro-
teomics to describe protein function, or uncover cellular targets
of compounds, employs different methods, depending upon the
nature of the study and the type of chemical probe used.
Activity-based probe profiling (ABPP) involves covalently
modifying the active site of an enzyme with a chemical probe
to allow for its isolation (Cravatt et al., 2008; Jeffery and Bogyo,
2003; Verhelst and Bogyo, 2005). This type of approach can yield
information on enzymatic activities (such as function, mecha-
nism, or active site properties) (Artavanis-Tsakonas et al.,
2006; Barglow and Cravatt, 2007; Greenbaum et al., 2002; Hek-
mat et al., 2005; Misaghi et al., 2006; Staub and Sieber, 2008),
groups of functionally related enzymes (Dalhoff et al., 2009; Mis-
aghi et al., 2006), and has been employed as a tool to understand
the virulence machinery of infectious bacterial and parasitic
species (Bottcher and Sieber, 2008b; Greenbaum et al., 2002;
Hang et al., 2006; Puri and Bogyo, 2009). As well, a competitive
variation of ABPP can identify highly potent and selective inhib-
itors, which outcompete the chemical probe (Bottcher and
Sieber, 2009; Leung et al., 2003). One interesting application of
ABPP used various b-lactammodified chemical probes to profile
the b-lactamase class of enzymes in both sensitive and resistant
S. aureus strains (Staub and Sieber, 2009). Several unique
enzyme activities were detected in the resistant strain including
two novel enzymes, potentially implicated in resistance in meth-
icillin-resistant S. aureus (MRSA). Chemical proteomics provides
the advantage of studying enzymatic properties in the context of
the proteome (not requiring recombinant protein); however, it is
limited by the ability to selectively target the active site of
a certain family of enzymes for covalent modification. As of
yet, selective ABPP probes are only available for a few classes
of enzymes and to increase the utility of this approach, new
chemical probes for other enzymatic families must be created.
In contrast to ABPP, compound-centric chemical proteomics
(CCCP) is largely about target discovery. Here mechanism of
action of a bioactive compound is inferred through the identifi-
cation of interacting cellular components, most often by affinity
chromatography and advanced mass spectrometry techniques
(Rix and Superti-Furga, 2009). CCCP has successfully identified
cellular targets for b-lactones (Bottcher and Sieber, 2008a;
Staub and Sieber, 2008), b-lactams (Staub and Sieber, 2008),
anticancer agents (Bantscheff et al., 2007; Rix et al., 2007),
and a variety of natural products (Piggott and Karuso, 2004;hts reserved
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with proteins in their natural environment, as they are ex-
pressed at physiological levels in the presence of binding part-
ners and any posttranslational modifications. However, CCCP
is only applicable to small molecules which can be chemically
modified for immobilization and does not distinguish specific
versus nonspecific interactions. Like other genomic ap-
proaches, tackling the proteome with small molecules as
modulators is an emerging technology with much promise to
characterize enzyme function and understand compound
mode of action.
Computationally-Assisted Chemical Genomics
Significant advances in computational power have made it
possible to streamline processes in the discovery of chemical
probes of biology and leads for drugs. A variety of databases
exist, from those that detail molecular structures (Klebe, 2000),
generate virtual libraries of small molecules (Barone et al.,
2001), and, most recently, provide gene expression profiles
(Faith et al., 2008). Additionally, computer programs and algo-
rithms are increasingly being developed to guide major steps
in chemical genomic studies. Genome-scale technologies are
yielding an overwhelming amount of valuable biological data
and, as such, computational analyses that apply the data to
generate and interpret network models, are expanding. In partic-
ular, with the growing challenges in microarray data analysis
come models with predictive power to assess the expression
profile of a compound of interest and assign its potential targets
(Bansal et al., 2006; di Bernardo et al., 2005; Hallen et al., 2006).
Recently, gene network inference algorithms have been thor-
oughly reviewed in Bansal et al. (2007). Such powerful computa-
tional analysis methods generally rely on integrating genetic
perturbation outputs, such as microarray experimental data,
with designed algorithms aimed at elucidating compound
targets and providing insights into biological networks. For
example, Halle´n et al. designed an algorithm (CutTree) for
genome-wide expression sets to identify the primary affected
genes of a chemical compound of interest (Hallen et al., 2006).
These were filtered out from genes that were indirectly affected
and finally relatively ranked according to their importance in the
microarray experiments. As a proof of principle, CutTree was
capable of identifying four of the five known primary targets of
galactose in yeast.
Another approach, mode of action by network identification
(MNI), distinguishes direct cellular targets of a bioactive
compound from other indirect gene products, which simply
result from changes in the activity of the primary target (di Ber-
nardo et al., 2005). Specifically, MNI computes the likelihood
that gene products and related pathways are the targets of
a small molecule. By first reverse engineering a network model
from a set of expression profiles, MNI then analyzes drug-
induced expression profiles to identify the genes targeted by
the compound. This method overcomes the limitation of gener-
ating whole-genome expression profiles that inherently do not
distinguish directly targeted genes, from those that are indirectly
regulated. Following validation of their method with a variety of
compound treatments, di Bernardo et al. uncovered thioredoxin
reductase as the target of PTSB, a previously uncharacterized
inhibitor of yeast growth (di Bernardo et al., 2005).Chemistry & BiOther computational methods include studies of small mole-
cule modeling and virtual screening (Eckert and Bajorath,
2007). Recently, Shen et al. proposed a strategy for antimicrobial
discovery that begins solely with computational methods to
identify chemical matter for novel targets (Shen et al., 2010).
Following genome-scale metabolic reconstruction in E. coli
and computational identification of essential metabolic reac-
tions, the enzymes of interest are docked against a library of
small molecules. Prediction through virtual screening leads to
the identification of a subset of inhibitors, which in turn are exper-
imentally validated for enzymatic and bacterial growth inhibition.
Largely, efforts in computationally assisted chemical genomics
are increasingly contributing to the prediction and understanding
of the biological system following chemical perturbation. In fact,
advanced statistical and computational analyses following
genome-scale studies are becoming inevitable, due to their
inherent overwhelming and complex nature.
Conclusions
Microbial systems, characterized by redundant and complex
functional pathways typify the modern view of the cell and, as
such, modern technologies, used to perturb, explore, and even
reconstruct these systems, are increasingly touted for studying
biological systems.
Chemical genomic approaches provide a platform that
contends with the complexity inherent in this postgenomic
view of cellular biology. Accordingly, our repertoire of chemical
matter is expanding, providing new means to globally study
biology, largely attributed to technological advances in synthetic
chemistry and natural product research. The creation of
genome-wide clone sets has been a technical feat that has
enabled remarkable advances in chemical genomics in model
microbes. The systematic modulation of gene dosage on a
genome scale has been among the most important technolog-
ical developments. Additionally, microarray- and promoter-
based transcriptional profiling experiments have made it
possible to thoroughly understand the cell’s immediate and
dynamic response to a perturbant on a genome-wide level.
Studies of the proteome using small molecules of interest rely
on direct physical interactions to infer compoundmode of action
and enzymatic activities. Overall, chemical genomic studies yield
information-rich data sets, often requiring additional means of
analysis. Hence, booming advances in computational power
are becoming a vital necessity. A plethora of innovative algo-
rithms make it possible to generate a wide array of outputs,
from network connectivity maps to simple clustograms. It is
important to note that a major caveat to all the aforementioned
methodologies is the abundant detection of indirect interactions.
Thus, more than ever, experimental validation is becoming a crit-
ical step in the pipeline for the discovery of biological probes.
Accordingly, the field is increasingly dependent on large collab-
orative efforts whereby biology, chemistry, biochemistry, and
computational sciences are at interplay. Overall, a better under-
standing can be obtained by integrating multiple genome-scale
techniques to piece together the complete extent of chemical-
genetic interactions. The assembly and chemical-genomic char-
acterization of a repertoire of diverse and novel bioactives will
provide an exceptional launching point for future studies
pursuing the activity of small molecule probes within the cellularology 17, June 25, 2010 ª2010 Elsevier Ltd All rights reserved 629
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Reviewnetwork. Alongwith providing new and extraordinary information
about the genetic networks of the model organism under study,
the field of chemical genomics remains largely untapped as
a paradigm for antibacterial drug discovery. Modern days in
chemical genomics are embracing a new emerging theme in
understanding biology, one that envisions the cell not as indi-
vidual components, but as a dynamic unity of complex and
robust pathways; a perspective that will largely benefit the study
of fundamental biological processes, not to mention drug
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